Osajima A, Anai H, Segawa K, Muta T, Takasugi M, Kuroiwa A
Second Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Nihon Jinzo Gakkai Shi. 1992 Sep;34(9):965-72.
The effects of loop diuretics (azosemide, ethacrynic acid and furosemide) on arginine vasopressin (AVP) receptor-adenylate cyclase components were compared in rat renal basolateral membranes. AVP binding was inhibited by these loop diuretics at concentrations above 10(-4) M. At the IC50 of azosemide and ethacrynic acid, the Kd values were significantly increased, while the Bmax values remained unchanged. These findings indicate an inhibitory effect of loop diuretics at high concentrations on the AVP binding to its receptors. Both the basal (AVP-unstimulated) and AVP-stimulated cyclic AMP productions were also inhibited by addition of these drugs. The inhibitions of the AVP binding and AVP-sensitive adenylate cyclase activity were dose-dependent. The above findings suggest that loop diuretics, especially azosemide and ethacrynic acid, can inhibit the basal and AVP-sensitive adenylate cyclase activities directly and also indirectly via the AVP receptor, at least in part. Comparing the loop diuretics, azosemide exerts a similar effect to ethacrynic acid, and they have a more potent antagonistic effect than furosemide with respect to AVP adenylate cyclase activation.
在大鼠肾基底外侧膜中比较了袢利尿剂(阿佐塞米、依他尼酸和呋塞米)对精氨酸血管加压素(AVP)受体 - 腺苷酸环化酶组分的影响。这些袢利尿剂在浓度高于10⁻⁴ M时可抑制AVP结合。在阿佐塞米和依他尼酸的IC50浓度下,Kd值显著增加,而Bmax值保持不变。这些发现表明高浓度的袢利尿剂对AVP与其受体的结合具有抑制作用。添加这些药物也会抑制基础(未受AVP刺激)和AVP刺激的环磷酸腺苷生成。AVP结合和AVP敏感的腺苷酸环化酶活性的抑制呈剂量依赖性。上述发现表明,袢利尿剂,尤其是阿佐塞米和依他尼酸,至少部分地可直接以及通过AVP受体间接抑制基础和AVP敏感的腺苷酸环化酶活性。比较这些袢利尿剂,阿佐塞米与依他尼酸发挥相似的作用,并且它们在AVP腺苷酸环化酶激活方面比呋塞米具有更强的拮抗作用。